Oncology Support
This collection holds anticancer and supportive-care medicines, including Nolvadex, Methotrexate Tablets and Zofran. It spans hormone therapy, cytotoxic treatment and targeted small molecules used against specific cancers.

Levothroid
25mcg · 50mcg · 75mcg · 100mcg · 112mcg · 125mcg · 200mcg
Levothyroxine tablets for hypothyroidism and to suppress thyroid-stimulating hormone. They replace the missing thyroid hormone.

Methotrexate Tablets
2.5mg · 5mg · 7.5mg · 10mg
Methotrexate tablets for rheumatoid arthritis and psoriasis. It calms the immune system's attack on joints and skin.

Tamoxifen Tablets
20mg
Tamoxifen tablets for breast cancer. It blocks oestrogen that some breast cancers rely on to grow.

Purinethol
50mg
Mercaptopurine tablets for acute lymphoblastic leukaemia. They interfere with the DNA building blocks in cancer cells.

Low Dose Naltrexone Capsules
1.5mg
Naltrexone capsules for fibromyalgia and fatigue in multiple sclerosis. This low dose is far below the addiction-treatment amount.

Fenbendazole Capsules
222mg · 444mg
Fenbendazole capsules for worm infections. It disrupts the worms' ability to absorb sugar, causing them to die.

Ibrutinib Capsules
140mg
Ibrutinib capsules for mantle cell lymphoma and chronic lymphocytic leukaemia. A targeted cancer medicine that blocks a specific protein driving the cancer.

Lenalidomide Capsules
10mg
Lenalidomide capsules for multiple myeloma and myelodysplastic syndromes. It is a thalidomide analogue that alters the immune system to attack cancer cells.

Ribociclib Tablets
200mg
Ribociclib tablets for breast cancer. It blocks enzymes that help cancer cells divide.
Key points
- Cancer medicine identity depends on the cancer type, stage, biomarkers and the treatment role a medicine plays, not on one shared label.
- Targeted therapies act on specific proteins or pathways involved in how cancer cells grow and spread.
- Supportive-care medicines manage treatment effects, such as nausea, or related complications, rather than acting directly on a tumour.
Hormone therapy, cytotoxic medicines and targeted therapy
Hormone-related medicines lead one part of this range, including Tamoxifen (Nolvadex) and anastrozole tablets (Altraz), used for Breast Cancer. Conventional cytotoxic medicines such as capecitabine (Zocitab) and cyclophosphamide (Cytoxan) sit alongside newer targeted small molecules, including imatinib (Gleevec) for chronic myeloid leukaemia, sorafenib (Nexavar) for kidney and thyroid cancers, and Ribociclib medicines.
Supportive care medicines in this collection
Zofran and Kytril contain ondansetron and granisetron, used for nausea and vomiting linked to cancer treatment. Zyloprim, prescribed for hyperuricaemia, is attached to this collection through a similar cancer-therapy link rather than an anticancer role of its own.























